False-positive positron emission tomography appearance with 18F-fluorodeoxyglucose after definitive radiotherapy for cancer of the mobile tongue

British Journal of Radiology

Volumn 82, Issue 973, 2009, Pages

  Ariji, Y ^a,b   Fuwa, N ^a   Kodaira, T ^a   Tachibana, H ^a   Nakamura, T ^a   Satoh, Y ^a   Ariji, E ^a,b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CESIUM 137; CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; GADOLINIUM PENTETATE; GOLD 198; NEDAPLATIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DRUG UPTAKE; FALSE POSITIVE RESULT; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; TONGUE CANCER; TREATMENT RESPONSE;

ADULT; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; FALSE POSITIVE REACTIONS; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; TONGUE NEOPLASMS; YOUNG ADULT;

EID: 58849094618     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/96087474     Document Type: Article

References (22)

1. Anzai Y, Carroll WR, Quint DJ, Bradford CR, Minoshima S, Wolf GT, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro -D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135-41.
2. Fischbein NJ, AAssar OS, Caputo GR, Kaplan MJ, Singer MI, Price DC, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Am J Neuroradiol 1998;19:1189-96.
3. Blodgett TM, Fukui MB, Snyderman CH, Branstetter BF 4th, McCook BM, Townsend DW, et al. Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake. Radiographics 2005;25:897-912.
4. Fukui MB, Blodgett TM, Snyderman CH, Johnson JJ, Myers EN, Townsend DW, et al. Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging. Radiographics 2005;25:913-30.
5. Rege SD, Chaiken L, Hoh CK, Choi Y, Lufkin R, Anzai Y, et al. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. Radiology 1993;189:807-12.
6. Greven KM, Williams DW 3rd, Keyes JW Jr, McGuirt WF, Watson NE Jr, Randall ME, et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 1994;74:1355-9.
7. Hautzel H, Muller-Gartner HW. Early changes in fluorine-18-FDG uptake during radiotherapy. J Nucl Med 1997;38:1384-6.
8. Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato M, et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigarphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 2003;44:198-206.
9. Nakamoto Y, Tatsumi M, Hammoud D, Cohade C, Osman MM, Wahl RL. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology 2005;234:879-85.
10. Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics 2004;24:1411-31.
11. Liu SH, Chang JT, Ng SH, Chan SC, Yen TC. False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a naso-pharyngeal carcinoma patient. Br J Radiol 2004;77:257-60.
12. Kawabe J, Higashiyama S, Okamura T, Torii K, Koyama K, Kawamura E, et al. FDG uptake by tongue and muscles of mastication reflecting increased metabolic activity of muscles after chewing gum. Clin Nucl Med 2003;28:220-1.
13. Davis E, Solis V, Rosenberg RJ, Spencer RP. Asymmetric tongue muscle uptake of F-18 FDG: possible marker for cranial nerve XII paralysis. Clin Nucl Med 2004;29:531-3.
14. Park YH, Baik JH, Ahn MI, Kim JY. FDG uptake in the diaphragm and crura, vocal cords, and base of tongue in a crying child. Clin Nucl Med 2005;30:752-3.
15. Kathula SK, Mantil J Chewing gum causing a very high FDG uptake of the tongue on PET scan. Clin Nucl Med 2007;32:122-3.
16. Rikimaru H, Kikuchi M, Itoh M, Tashiro M, Watanabe M. Mapping energy metabolism in jaw and tongue muscles during chewing. J Dent Res 2001;80:1849-53.
17. Tashiro M, Fujimoto T, Itoh M, Kubota K, Fujiwara T, Miyake M, et al. 18F-FDG PET imaging of muscle activity in runners. J Nucl Med 1999;40:70-6.
18. Yasuda S, Fujii H, Takahashi W, Takagi S, Ide M, Shohtsu A. Elevated F-18 FDG uptake in the skeletal muscle. Clin Nucl Med 1998;23:716-7.
19. Pappas GP, Olcott EW, Drace JE. Imaging of skeletal muscle function using 18FDG PET: force production, activation, and metabolism. J Appl Physiol 2001;90:329-37.
20. Barrington SF, Maisey MN. Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam. J Nucl Med 1996;37:1127-9.
21. Yoshioka Y, Yoshida K, Shimizutani K, Furukawa S, Inoue T, Teshima T, et al. Proposal of a new grading system for evaluation of tongue hemiatrophy as a late effect of brachytherapy for oral tongue cancer. Radiother Oncol 2001;61:87-92.
22. Urashima Y, Nakamura K, Shioyama Y, Sasaki T, Ohga S, Toba T, et al. Long-term functional outcome of brachytherapy for carcinoma of the mobile tongue: focus on the atrophic change of irradiated tongue. Jpn J Clin Oncol 2006;36:681-7.